Topoisomerase Inhibitor [EPC]

76948 reported adverse events

Drugs of this class: ETOPOSIDE TOPOTECAN

These side effects are most commonly reported by patients taking drugs of the Topoisomerase Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 8763
1 FEBRILE NEUTROPENIA 8088
2 NEUTROPENIA 5470
3 DRUG INEFFECTIVE 4931
4 DISEASE PROGRESSION 4863
5 THROMBOCYTOPENIA 4385
6 PYREXIA 3727
7 ANAEMIA 3689
8 PRODUCT USE IN UNAPPROVED INDICATION 3209
9 SEPSIS 3133
See all common reactions for Topoisomerase Inhibitor [EPC]

Drugs of the Topoisomerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 148 0.9673
1 THYMUS HYPOPLASIA 152 0.8736
2 HUMAN BOCAVIRUS INFECTION 133 0.7037
3 DESMOPLASTIC SMALL ROUND CELL TUMOUR 49 0.5632
4 OVARIAN GERM CELL TERATOMA 37 0.4625
5 BASAL GANGLION DEGENERATION 35 0.3723
6 NEPHROBLASTOMA 46 0.3622
7 MEDULLOBLASTOMA RECURRENT 40 0.3540
8 RENAL SALT-WASTING SYNDROME 136 0.3469
9 NEUROBLASTOMA RECURRENT 68 0.3350
See all enriched reactions for Topoisomerase Inhibitor [EPC]